Company name
Vaderis Therapeutics AG
Company profile
Vaderis is a science-driven, patient-focused biotech dedicated to bringing breakthrough therapies to people with Hereditary Hemorrhagic Telangiectasia and other rare vascular diseases. Guided by deep biological insight, rigorous science, and focused execution, we advance with purpose and urgency, driven by patients, inspired by possibility, and committed to pioneering care for people with unmet needs.
Date, time and room information
Monday, May 4, 18:00 - 18:15, room Montreal
Category
Clinical stage development company
Title of the presentation
Pioneering targeted therapies in rare vascular disease
Speaker information
| Name | Position | Institution |
|---|---|---|
| Pierre Saint-Mezard | C.S.O. and Co-founder | Vaderis Therapeutics |
